Valuation: Terumo Corporation

Market Cap 3,376B 20.63B 18.1B 16.86B 15.5B 29.06B 1,971B 29.56B 200B 78.27B 977B 77.44B 75.76B P/E 2027 *
20.1x
P/E 2028 * 18x
Enterprise Value 3,445B 21.04B 18.47B 17.2B 15.82B 29.65B 2,010B 30.16B 204B 79.86B 997B 79B 77.29B EV / Sales 2027 *
2.77x
EV / Sales 2028 * 2.57x
Free-Float
97.07%
Yield 2027 *
1.57%
Yield 2028 * 1.75%
1 day+4.08%
1 week+6.34%
Current month+6.65%
1 month+7.71%
3 months+15.91%
6 months+17.86%
Current year+4.96%
1 week 2,133
Extreme 2133
2,403
1 month 2,133
Extreme 2133
2,403
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.08%+6.34%-8.01%+5.00% 20.63B
+2.40%+8.75%-14.56%-1.76% 187B
+1.77%+7.50%-4.77%+0.31% 111B
+0.58%+6.75%+10.73%+71.68% 62.18B
+0.34%-6.62%+21.84%+49.32% 48.4B
+1.24%+9.41%-8.12%-39.86% 45.83B
-0.88%+8.18% - - 34.26B
+1.32%+5.75%-15.46%-39.35% 28.88B
-0.77%-7.06%+31.70%-9.49% 23.72B
+1.43%+10.60%+1.98%+3.26% 22.45B
Average +1.15%+1.61%+1.70%+4.35% 58.44B
Weighted average by Cap. +1.46%+3.83%-3.12%+6.43%

Financials

2027 *2028 *
Net sales 1,241B 7.58B 6.66B 6.2B 5.7B 10.69B 724B 10.87B 73.52B 28.78B 359B 28.47B 27.85B 1,321B 8.07B 7.08B 6.59B 6.06B 11.37B 771B 11.56B 78.22B 30.62B 382B 30.29B 29.63B
Net income 168B 1.03B 902M 840M 773M 1.45B 98.23B 1.47B 9.97B 3.9B 48.72B 3.86B 3.78B 188B 1.15B 1.01B 937M 862M 1.62B 110B 1.64B 11.12B 4.35B 54.32B 4.3B 4.21B
Net Debt 68.22B 417M 366M 341M 313M 587M 39.82B 597M 4.04B 1.58B 19.75B 1.56B 1.53B 16.78B 103M 89.97M 83.78M 77.06M 144M 9.79B 147M 994M 389M 4.86B 385M 377M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
29/07/26 JP¥2,382.50 +4.08% 6,546,900
28/07/26 JP¥2,289.00 +1.78% 5,281,100
27/07/26 JP¥2,249.00 +3.90% 4,788,800
24/07/26 JP¥2,164.50 +0.30% 2,693,400
23/07/26 JP¥2,158.00 -1.86% 3,500,500
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,289.00JPY
Average target price
3,023.08JPY
Spread / Average Target
+32.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock